Prosight Management, LP - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 45 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Links
Filings
Quarter-by-quarter ownership
Prosight Management, LP ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2018$1,467,000
+20.1%
421,414
+73.6%
1.08%
+40.3%
Q1 2018$1,221,000
-58.5%
242,689
-50.6%
0.77%
-64.6%
Q4 2017$2,939,000–491,395–2.16%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2017
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders